Skip to main content
SpringerLink
Log in

Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal adenocarcinoma

  • Pancreas
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the feasibility of CT perfusion performed during routine multiphase contrast-enhanced CT on a 160 mm wide-coverage 256-slice scanner in patients with pancreatic ductal adenocarcinoma (PDAC).

Methods

Fifty-seven patients had a CT perfusion acquisition during their routine multiphase CT. Perfusion was performed 5 to 42.5 s (15 passes at 2.5 s intervals) after intravenous contrast administration (4.2–5 ml/s), followed by pancreatic parenchymal and portal venous phases for clinical interpretation. Perfusion maps were generated and blood flow (BF), blood volume (BV), and permeability surface area product (PS) for tumor and uninvolved pancreas were calculated using deconvolution algorithms and compared to existing similar publications. Radiation dose information was recorded and size-specific dose estimate (SSDE) was calculated using body dimensions.

Results

Diagnostic quality of standard images was unaffected by performing the perfusion acquisition. Average tumor center BF was 20.8 ± 12.1 ml/100 g/min, BV 2.5 ± 2.1 ml/100 g and PS 15.5 ± 39.4 ml/100 g/min. Average pancreas BF was 90.8 ± 50.2 ml/100 g/min, BV 11.9 ± 4.3 ml/100 g and PS 33.6 ± 27.7 ml/100 g/min. For the perfusion acquisition, mean SSDE was 57 ± 11 mGy, CTDIvol 43 ± 6 mGy and DLP 685 ± 100 mGy-cm.

Conclusion

Adding a perfusion CT acquisition to standard pancreatic CT protocol is feasible using a wide-detector 256-slice CT scanner and adds quantitative information while maintaining diagnostic quality of the standard of care examination. This novel protocol adds no time or cost to the examination and yields perfusion parameters that are comparable to existing literature using a separate dedicated perfusion protocol.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Nelson DW, Chang S-C, Grunkemeier G, et al (2018) Resectable Distal Pancreas Cancer: Time to Reconsider the Role of Upfront Surgery. Ann Surg Oncol 25:4012–4019.

    Article  Google Scholar 

  2. Zhong J, Switchenko J, Behera M, et al (2018) Chemotherapy with or Without Definitive Radiation Therapy in Inoperable Pancreatic Cancer. Ann Surg Oncol 25:1026–1033.

    Article  Google Scholar 

  3. Cancer Stat Facts: Pancreatic Cancer [SEER Cancer Stat Facts Web site]. Available at: http://seer.cancer.gov/statfacts/html/pancreas.html. Accessed June 10, 2020.

  4. Luberice K, Downs D, Sadowitz B, et al (2017) Has survival improved following resection for pancreatic adenocarcinoma? Am J Surg 214:341–346.

    Article  Google Scholar 

  5. Cassinotto C, Mouries A, Lafourcade J-P, et al (2014) Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy. Radiology 273:108–116.

    Article  Google Scholar 

  6. Ferrone CR, Marchegiani G, Hong TS, et al (2015) Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg 261:12–17.

    Article  Google Scholar 

  7. Katz MHG, Fleming JB, Bhosale P, et al (2012) Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer 118:5749–5756.

    Article  Google Scholar 

  8. Klotz E, Haberland U, Glatting G, et al (2015) Technical prerequisites and imaging protocols for CT perfusion imaging in oncology. Eur J Radiol 84:2359-2367.

    Article  Google Scholar 

  9. Prezzi D, Khan A, Goh V (2015) Perfusion CT imaging of treatment response in oncology. Eur J Radiol 84:2380–2385.

    Article  Google Scholar 

  10. Fukukura Y, Takumi K, Higashi M, et al (2014) Contrast-enhanced CT and diffusion-weighted MR imaging: Performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma. Eur J Radiol 83:612–619.

    Article  Google Scholar 

  11. D’Onofrio M, Gallotti A, Mantovani W, et al (2013) Perfusion CT can predict tumoral grading of pancreatic adenocarcinoma. Eur J Radiol 82:227–233.

    Article  Google Scholar 

  12. Hamdy A, Ichikawa Y, Toyomasu Y, et al (2019) Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience. Radiology 292:628-635.

    Article  Google Scholar 

  13. Aslan S, Nural MS, Camlidag I, et al (2019) Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions. Abdom Radiol 44:593–603.

    Article  Google Scholar 

  14. AAPM Task Group 204. AAPM Report No. 204 Size-Specific Dose Estimates (SSDE) in Pediatric and Adult Body CT Examinations. 2011. Available at: https://www.aapm.org/pubs/reports/rpt_204.pdf. Accessed June 10, 2020.

  15. AAPM Task Group 23. AAPM Report No. 96 The Measurement, Reporting, and Management of Radiation Dose in CT. 2008. Available at: https://www.aapm.org/pubs/reports/RPT_96.pdf. Accessed June 10, 2020.

  16. Delrue L, Blanckaert P, Mertens D, et al (2011) Assessment of Tumor Vascularization in Pancreatic Adenocarcinoma Using 128-Slice Perfusion Computed Tomography Imaging. J Comput Assist Tomogr 35:434–438.

    Article  Google Scholar 

  17. Xu J, Liang Z, Hao S, et al (2009) Pancreatic adenocarcinoma: dynamic 64-slice helical CT with perfusion imaging. Abdom Imaging 34:759–766.

    Article  Google Scholar 

  18. Yadav AK, Sharma R, Kandasamy D, et al (2016) Perfusion CT – Can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum? Pancreatology 16:979–987.

    Article  Google Scholar 

  19. Schneeweiß S, Horger M, Grözinger A, et al (2016) CT-perfusion measurements in pancreatic carcinoma with different kinetic models: Is there a chance for tumour grading based on functional parameters? Cancer Imaging 16:43.

    Article  Google Scholar 

  20. Miles KA (2003) Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 76:S36–S42.

    Article  Google Scholar 

  21. Kaufmann S, Schulze M, Horger T, et al (2015) Reproducibility of VPCT Parameters in the Normal Pancreas. Acad Radiol 22:1099–1105.

    Article  Google Scholar 

  22. Bao J, Liu A, Zhao C, et al (2019) Correlation between dual-energy computed tomography single scan and computed tomography perfusion for pancreatic cancer patients: initial experience. J Comput Assist Tomogr 43:599–604. https://doi.org/10.1097/RCT.0000000000000878.

    Article  Google Scholar 

  23. Xie Q, Wu J, Tang Y, et al (2013) Whole-organ CT perfusion of the pancreas: impact of iterative reconstruction on image quality, perfusion parameters and radiation dose in 256-slice CT-preliminary findings. PloS One 8:e80468. https://doi.org/10.1371/journal.pone.0080468.

    Article  Google Scholar 

Download references

Funding

This research was supported by GE Healthcare.

Author information

Authors and Affiliations

  1. Department of Radiology, University of Washington School of Medicine, 1959 NE Pacific Street, Box 357115, Seattle, WA, 98195, USA

    Ryan B. O’Malley, Erik V. Soloff, Danielle H. Cox, Nitin Desai, Janet M. Busey & Carolyn L. Wang

  2. Department of Medicine, Division of Oncology, University of Washington School of Medicine, 1959 NE Pacific Street, Seattle, WA, 98195, USA

    Andrew L. Coveler

  3. Seattle Cancer Care Alliance, 825 Eastlake Ave E, Seattle, WA, 98109, USA

    Greta M. Valentin

Authors
  1. Ryan B. O’Malley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erik V. Soloff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew L. Coveler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Danielle H. Cox
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nitin Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Janet M. Busey
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Greta M. Valentin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Carolyn L. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryan B. O’Malley.

Ethics declarations

Conflict of interest

All author declare that they have no conflict of interest.

Consent to participate

All subjects signed written informed consent before participating.

Ethical approval

IRB approval was obtained for this prospective research.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Malley, R.B., Soloff, E.V., Coveler, A.L. et al. Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal adenocarcinoma. Abdom Radiol 46, 1992–2002 (2021). https://doi.org/10.1007/s00261-020-02786-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02786-y

Keywords

Search

Navigation